The Tufts-CEVR HEOR Leaders Survey: Health Policy Challenges and Opportunities - Center for the Evaluation of Value and Risk in Health

How are pharma #HEOR teams informing industry responses to developments like the #IRA, state #PDABs, and rules for sharing economic evidence with payers?

Read CEVR’s report exploring the results of our new national survey of industry HEOR leaders to find out: tinyurl.com/ywjsntyy

Specialist Physicians’ Perspectives on State PDABs: Access, Affordability, and Administrative Burden - Magnolia Market Access As states expand PDAB authority to set Upper Payment Limits (UPLs) on high-cost therapies, Magnolia Market Access surveyed physicians in Colorado, Maryland, Oregon, and Washington to understand how…

96% of specialist physicians surveyed are concerned that upper payment limits by #PDABs will lead to non-medical switching, restricting patient access to needed drug therapies.

Patient advocate raises concerns about Minnesota's Prescription Drug Affordability Board potentially affecting AIDS Drug Assistance Program and 340B program. Calls for meaningful community engagement from people living with HIV in PDAB decisions. #PDABs #HIVAdvocacy buff.ly/3VCorql

Maryland PDAB Comments Raise Advocates’ Concerns The March meeting of the […]

Value of Care Coalition raises alarm over Maryland PDAB members' comments dismissing impact analyses and rushing medication reviews. For people relying on medications, thorough assessment is "the bare minimum." #DrugPricing #PDABs #PatientAccess

PDAB: A mysterious acronym that could affect your health We must make medications affordable without sacrificing access

#LGBTQ+ advocacy leaders from MD and VA raise concerns about #PDABs - boards that review drug costs but may limit access to vital medications for people living with #HIV and chronic conditions. "We need solutions that make meds affordable without sacrificing access." #HealthEquity

A pharmacist speaks with a patient in a pharmacy setting, discussing medication options. The text includes an op-ed title addressing concerns about Maryland’s Prescription Drug Affordability Board. It encourages readers to engage with the subject through a patient survey regarding drug affordability

Patients deserve better. 🧡 Melodie Narain-Blackwell urges Maryland’s PDAB to hit pause before worsening health disparities. Read the op-ed, take the patient survey, and make your voice heard.

Read: heyor.ca/GHd6Ar
Survey: eachpic.org/survey/ #PDABs

A graphic featuring a forest background with the text "ADVOCACY ALERT" at the top. Below, it reads: "Calling All Oregon Patients and Caregivers: Share Your Perspective On Prescription Drugs." The design uses green and white colors, with an outline of Oregon at the bottom.

Are you an Oregon resident currently taking any of the 27 medications the Prescription Drug Affordability Board is reviewing? They need to hear from you! Use the link from our partners at the PIC to learn about this opportunity and more!

Link: eachpic.org/pic-voices/

#PDABs

Insulin Prices Dropped. But Some Poor Patients Are Paying More. A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.

CANN wishes to express our gratitude to Gov. Youngkin for his veto of HB1724. #PDABs repeat the problems in the Inflation Reduction Act, incentivizing upward wealth redistribution at the expense of healthcare access.

Read @nytimes.com piece: www.nytimes.com/2025/01/16/h...